Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy
Advanced Healthcare Materials · 2026
DOI: 10.1002/adhm.202505434 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2026. Verfasst von Nana Su und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, P. R. China. Hauptthemen laut MEDLINE: Theranostic Nanomedicine, Photochemotherapy, Optical Imaging, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Key Laboratory of Molecular Imaging, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Activable theranostic probes offer significant potential for the precise diagnosis and therapy in cancer treatment. The core challenge in realizing this target is how to manipulate therapeutic and imaging activities by a simple yet efficient method. To address this, an exceptional “ charge regulation ” strategy to furnish an activable theranostic probe, GSH‐Cy5 is employed. The probe undergoes tumor‐specific activation via glutathione (GSH)‐triggered decationization, concurrently enhancing its anti‐cancer activity and tumor‐imaging contrast. Beyond this theranostic activity, GSH‐Cy5 also exhibits synergistic photothermal (PTT) and photodynamic (PDT) effects, which further amplify its therapeutic efficacy by inducing cell death through mitochondria‐mediated pathways. In vivo experiments demonstrated the effectiveness of GSH‐Cy5 , as it successfully enabled tumor visualization and selective therapy in tumor‐bearing mouse models. This work establishes GSH‐Cy5 as a transformative theranostic platform, while the “ charge regulation ” strategy opens new avenues for designing activable cyanine probes in precise tumor treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing, P. R. China.
- Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, P. R. China.
ORCID-Profile: Xiaole Zhou
Förderung
- National Natural Science Foundation of China
- Shanghai Key Laboratory of Molecular Imaging
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Su, N., Lin, Y., Zhang, B., Kang, Y., Li, Y., Lu, C., Zhou, X., Huang, Q., & Wang, L. (2026). Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202505434
Vancouver
Su N, Lin Y, Zhang B, Kang Y, Li Y, Lu C, et al. Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy. Advanced Healthcare Materials. 2026. doi:10.1002/adhm.202505434
BibTeX
@article{Su2026,
author = {Su, Nana and Lin, Yanhong and Zhang, Bingling and Kang, Yuxiao and Li, Yuhang and Lu, Chang and Zhou, Xiaole and Huang, Qingqing and Wang, Leyu},
title = {Charge‐Regulation Activable Theranostic Probe for Tumor‐Specific Fluorescence Imaging and Chemo‐Phototherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
doi = {10.1002/adhm.202505434}
}
EUVIMED